Speaker: 

Randy Lesh, MD, Resident, Geisinger - has nothing to disclose.

Moderator: 

Ellen Penn, MD, Resident, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Review and understand the epidemiology, genetics, and pathophysiology of HHT.
• Review the diagnostic criteria for HHT.
• Review the available topical and systemic treatment modalities for HHT.
• Discuss and compare surgical options for HHT.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Aileen Wertz, MD; Kenneth Altman, MD, PhD; Vincent Desiato, DO; Curtis Gehman, PA-C; Michele Shulski, BSN, RN and Kathryn Kole, CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None